Globe Life (GL) Earnings Analysis
Globe Life (GL) next reports earnings on 2026-10-28, consensus EPS 4.71 USD. Last quarter (2026-07-22) it missed with EPS 3.61 USD vs 3.67 USD est (-1.6%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 12.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GL next report earnings?
| Next earnings date | 2026-10-28 |
|---|---|
| Consensus EPS estimate | 4.71 USD |
| Revenue estimate | 1.61B |
GL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-22 | 3.61 USD | 3.67 USD | -1.6% | Miss |
| 2026-04-22 | 3.43 USD | 3.47 USD | -1.2% | Miss |
| 2026-02-04 | 3.39 USD | 3.44 USD | -1.5% | Miss |
| 2025-10-22 | 4.81 USD | 4.6 USD | +4.6% | Beat |
| 2025-07-23 | 3.27 USD | 3.25 USD | +0.6% | Beat |
| 2025-04-30 | 3.07 USD | 3.23 USD | -5% | Miss |
| 2025-02-05 | 3.14 USD | 3.12 USD | +0.6% | Beat |
| 2024-07-24 | 2.97 USD | 2.91 USD | +2.1% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
GL valuation and analyst view
| Trailing P/E | 12.01 |
|---|---|
| Trailing EPS | 14.98 USD |
| Price / book | 2.45 |
| Dividend yield | 0.65% |
| Market cap | 14.25B |
| Analyst consensus | Hold (10 buy / 11 hold / 7 sell) |
| Avg price target | 181.4 USD |
Related research pages
Frequently asked questions
When is Globe Life (GL)'s next earnings date?
Globe Life is next scheduled to report on 2026-10-28, with a consensus EPS estimate of 4.71 USD and revenue estimate of 1.61B.
Did GL beat earnings last quarter?
In its 2026-07-22 report, GL posted EPS of 3.61 USD versus a 3.67 USD estimate — a miss of 1.6%.
What is GL's earnings track record?
Over the last 8 reported quarters with consensus data, GL beat estimates 4 times (50%).
What is GL's current P/E ratio and EPS?
GL trades at a trailing P/E of 12.01 on trailing EPS of 14.980116416497946 USD.
What do analysts rate GL?
Analyst consensus is "Hold" across 28 ratings (1 strong buy, 9 buy, 11 hold, 7 sell, 0 strong sell). Average 12-month price target: 181.4 USD.